ArticleAdvances in radiation oncology2026
Minimization of Geometric Uncertainties and Setup Errors Improves Tumor Control for Intracranial Stereotactic Radiosurgery.
Article in Advances in radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To assess the lesion-level effect of 1-2-mm geometric uncertainty on tumor control probability (TCP) in brain-metastasis stereotactic radiosurgery (SRS), assuming a uniform 2-mm planning target volume margin. Methods and Materials: We retrospectively analyzed 75 brain metastases in 50 patients who underwent linear accelerator-based SRS. Geometric uncertainty was simulated by applying positional shifts to the treatment plan, and the resulting reduction in TCP was quantified. The resulting dosimetric and radiobiological characteristics were compared between tumors ≤20 mm and those >20 mm. Results: Tumor size modulated the impact of geometric uncertainty. Small lesions (≤20 mm) exhibited steeper dose gradients (gradient index, 3.6 vs 2.6; Conclusions: Patients with larger tumors (>20 mm) may be most vulnerable to a significant loss of tumor control from geometric uncertainties in SRS. This analysis shows promise for personalizing treatment delivery, supporting a shift from applying fixed planning target volume margins toward strategies such as fractionated radiation therapy tailored to individual tumor size and radiobiological characteristics. This hypothesis-generating study requires external validation, with fractionated stereotactic radiation therapy being a subject for future investigation.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.